Israel Englander’s Precision BioSciences DTIL Stock Holding History

Israel Englander’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,000	Closed	-$250K	–	6036
2020 Q4	$250K	Buy	+1,000	New	+$245K	﹤0.01%	4676

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Israel Englander's DTIL Position: Q2 2026 in Review

Israel Englander sold out of Precision BioSciences (DTIL) in Q2 2026, closing a stake of 27,684 shares — an estimated $152K sold.

Israel Englander first reported a position in DTIL in Q1 2019 and held it in 20 quarters. The position peaked at $6.43M in Q2 2021. 94 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Israel Englander reported no remaining Precision BioSciences position as of Q2 2026 after selling out during the quarter.
Israel Englander sold 27,684 Precision BioSciences shares in Q2 2026, an estimated $152K.
Israel Englander first reported a position in Precision BioSciences in Q1 2019 and held it in 20 quarters.
Israel Englander's Precision BioSciences position peaked at $6.43M in Q2 2021.
94 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.